Why the study?
Does atrial overdrive pacing terminate drug-resistant ventricular tachycardia in a patient with dilated cardiomyopathy?
Population
A patient with dilated cardiomyopathy, sinus node dysfunction, and drug-resistant ventricular tachycardia (VT)
Design
Case_report
Authors
Loading...
May offer noninvasive VT termination option in select cases; single report leaves open efficacy, safety, and need for trials.
Does atrial overdrive pacing terminate drug-resistant ventricular tachycardia in a patient with dilated cardiomyopathy?
Atrial overdrive pacing via an implanted pacemaker and external activator offers a potentially safer alternative to ventricular pacing for terminating drug-resistant ventricular tachycardia.
Tanabe et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: